The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Sofinnova Management Vii, L.l.c. since 2012.
The trader's CIK number is 1421501.
At the time of the last reporting, Sofinnova Management Vii, L.l.c. was the 10% Owner of Aerie Pharmaceuticals Inc. (stock ticker symbol AERI).
Also see all insider trading activities at Aerie Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | HPTX | 0 | $0 | 23,625 | $709,222 | 0 | $0 |
| 2012 | HPTX | 563,000 | $5,630,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | DRTX | 588,236 | $5,294,124 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | AERI | 0 | $0 | 323,932 | $5,182,912 | 0 | $0 |
| 2013 | AERI | 285,000 | $2,850,000 | 0 | $0 | 0 | $0 |
1. Hyperion Therapeutics Inc (HPTX)
2. Durata Therapeutics, Inc. (DRTX)
3. Aerie Pharmaceuticals Inc (AERI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-03-04 | HPTX | Sale | 23,625 | 30.02 | 709,222 |
| 2012-07-31 | HPTX | Buy | 563,000 | 10.00 | 5,630,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-07-24 | DRTX | Buy | 588,236 | 9.00 | 5,294,124 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-05-22 | AERI | Sale | 323,932 | 16.00 | 5,182,912 |
| 2013-10-25 | AERI | Buy | 285,000 | 10.00 | 2,850,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sofinnova Management Vii, L.l.c. (10% Owner of Aerie Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.